Of all study patients reporting a decrease in opioid use, significantly more in the ZTlido ® group experienced a 20% or greater reduction in opioid use, compared with those treated with 5% lidocaine ...
Preliminary Fourth Quarter and Full Year 2024 Net Product Revenue (Unaudited) Based on preliminary unaudited financial information, Axsome expects total product revenue to be approximately $118.3 ...